Evidence for monoaminergic involvement in triadimefon-induced hyperactivity

[1]  B. Scatton,et al.  Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  M. Menon,et al.  Evidence for presynaptic antagonism by amantadine of indirectly acting central stimulants , 1983, Psychopharmacology.

[3]  M. Sansone.  Facilitating effects of chlordiazepoxide on locomotor activity and avoidance behaviour of reserpinized mice , 1978, Psychopharmacology.

[4]  T. Lewander,et al.  Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after α-methyl-p-tyrosine; time- and dose-response relationships , 1978, Naunyn-Schmiedeberg's Archives of Pharmacology.

[5]  T. Lewander,et al.  The relationship between amphetamine antagonism and depletion of brain catecholamines by alpha-methyl-p-tyrosine in rats , 1978, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  B. Cooper,et al.  Comparison of tyrosine hydroxylase and dopamine-Β-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity , 1974, Psychopharmacologia.

[7]  D. Brenneman,et al.  Effect of dietary lipid on locomotor activity and response to psychomotor stimulants , 2004, Psychopharmacology.

[8]  J. Bapna,et al.  Modification of the effect of some central stimulants in mice pretreated with α-methyl-l-tyrosine , 2004, Psychopharmacologia.

[9]  G. Arbuthnott,et al.  Amphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis Study , 1988, Journal of neurochemistry.

[10]  L. Reiter,et al.  Hyperactivity induced by triadimefon, a triazole fungicide. , 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[11]  P. Bushnell.  Differential effects of amphetamine and related compounds on locomotor activity and metabolic rate in mice , 1986, Pharmacology Biochemistry and Behavior.

[12]  C. Winter,et al.  Factors influencing grape worker susceptibility to skin rashes , 1985, Bulletin of environmental contamination and toxicology.

[13]  G. Zweig,et al.  Percutaneous absorption of triadimefon in the adult and young male and female rat. , 1984, Toxicology and applied pharmacology.

[14]  B. McMillen.  CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs , 1983 .

[15]  J. Freeman,et al.  Antagonism of methylphenidate-induced behavior by neostigmine or hemicholinium-3 , 1981, Neuropharmacology.

[16]  H. Meltzer,et al.  Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats , 1980, Pharmacology Biochemistry and Behavior.

[17]  D. German,et al.  Functional and pharmacological significance of brain dopamine and norepinephrine storage pools. , 1980, Biochemical pharmacology.

[18]  A. M. Skidmore,et al.  Diclobutrazol: a new systemic fungicide. , 1980 .

[19]  H. Buchenauer.  Inhibition of ergosterol biosynthesis by triadimenol in Ustilago avenae , 1978 .

[20]  P. A. Shore,et al.  Reserpine: Basic and Clinical Pharmacology , 1978 .

[21]  C. Braestrup.  Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats , 1977, The Journal of pharmacy and pharmacology.

[22]  H. Buchenauer.  Mode of action of triadimefon in Ustilago avenae , 1977 .

[23]  L. Reiter,et al.  Developmental and behavioral changes in the rat during chronic exposure to lead. , 1975, Environmental health perspectives.

[24]  K. E. Moore,et al.  D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo. , 1975, The Journal of pharmacology and experimental therapeutics.

[25]  B. Culver,et al.  Measurement of the effects of drugs on activity of permanent groups of rats. , 1975, Psychopharmacology communications.

[26]  K. E. Moore,et al.  Effects of alpha-methyltyrosine on d-amphetamine-induced release of endogenously synthesized and exogenously administered catecholamines from the cat brain in vivo. , 1974, The Journal of pharmacology and experimental therapeutics.

[27]  M. Lipton.  Neuropsychopharmacology of monoamines and their regulatory enzymes. , 1974, Advances in biochemical psychopharmacology.

[28]  K. E. Moore,et al.  The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs. , 1973, Neuropharmacology.

[29]  J. Scheel-Krüger,et al.  Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. , 1971, European journal of pharmacology.

[30]  H. Frey,et al.  Different central mediation of the stimulant effects of amphetamine and its p-chloro analogue. , 1968, Biochemical pharmacology.

[31]  A. Randrup,et al.  Behavioural Stereotypies Induced by Pharmacological Agents , 1968 .

[32]  K. Moore,et al.  Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines. , 1968, The Journal of pharmacology and experimental therapeutics.

[33]  G. Y. Lesher,et al.  Pharmacologic studies with 7-benzyl-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid. , 1967, The Journal of pharmacology and experimental therapeutics.

[34]  J. Stolk,et al.  Enhanced stimulant effects of d-amphetamine on the spontaneous locomotor activity of rats treated with reserpine. , 1967, The Journal of pharmacology and experimental therapeutics.

[35]  N. Andén.  Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system. , 1967, European journal of pharmacology.

[36]  S. Tenen,et al.  Antiamphetamine effects following inhibition of tyrosine hydroxylase. , 1966, The Journal of pharmacology and experimental therapeutics.

[37]  E. Rosengren,et al.  TIME CORRELATION BETWEEN THE EFFECTS OF RESERPINE ON BEHAVIOUR AND STORAGE MECHANISM FOR ARYLALKYLAMINES. , 1963, Acta physiologica Scandinavica.